Association of the factor XII 46C>T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study (Q44123484)

30 November 2017

Association of the factor XII 46C>T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study (English)

1 reference

30 November 2017

1 reference

coronary artery disease

1 reference

Francesco Zito

1

1 reference

30 November 2017

Gordon D O Lowe

2

1 reference

30 November 2017

Ann Rumley

3

1 reference

30 November 2017

Alex D McMahon

4

1 reference

30 November 2017

Steve E Humphries

5

1 reference

30 November 2017

WOSCOPS Study Group West of Scotland Coronary Prevention Study

6

1 reference

30 November 2017

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

165

1 reference

30 November 2017

1

1 reference

30 November 2017

153-158

1 reference

Mechanisms of activation of the classical pathway of complement by Hageman factor fragment

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

A comparision of the abilities of plasma kallikrein, β-factor XIIa, factor XIa and urokinase to activate plasminogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

Fibrinolytic properties of activated FXII

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

Hageman factor and risk of myocardial infarction in middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

Risk of coronary heart disease and activation of factor XII in middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

Baseline risk factors and their association with outcome in the West of Scotland Coronary Prevention Study. The West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

An enzyme-linked immunosorbent assay (ELISA) for the measurement of activated factor XII (Hageman factor) in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

A simple salting out procedure for extracting DNA from human nucleated cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

The scanning model for translation: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

Depression of factor XII-dependent fibrinolytic activity in survivors of acute myocardial infarction at risk of reinfarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900196-X

10.1016/S0021-9150(02)00196-X

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference